CD133, VEGFR-2, and CD34 also showed significantly higher expression in the stroma of primary NPC tissues compared with inflammatory tissues (CD133, P = 0.006; VEGFR-2, P = 0.04; CD34, P < 0.001). This evidence concerns the gene PROM1 and nasopharyngeal carcinoma.